Monograph Details
|
|
Pain & Pyrexia
> Narcotic analgesics
|
|
OXYIR |
| Manufacturer |
|
Purdue Pharma L.P. |
| Legal Classification |
|
CII |
| Pharmacological Class |
|
Opioid. |
| Generic Name |
|
Oxycodone HCl 5mg; caps. |
| Also |
|
• OXYFAST ORAL CONCENTRATE
|
| Indications |
|
Moderate to moderately severe pain. |
| Children |
|
Not recommended. |
| Adults |
|
Individualize. Usually 5mg every 6 hrs as needed. OxyFast is a highly concentrated soln, use carefully. |
| Contraindications |
|
Severe respiratory depression. Acute or severe asthma or hypercarbia. Paralytic ileus. |
| Precautions |
|
Head injury. Increased intracranial pressure. CNS depression. Coma. Toxic psychosis. Convulsive disorders. Shock. Impaired pulmonary, renal, hepatic, thyroid, or adrenocortical function. GI or GU obstruction. Acute abdomen. Biliary tract disease. Acute pancreatitis. Kyphoscoliosis (associated with respiratory depression). Drug abusers. Acute alcoholism. Delirium tremens. Elderly. Debilitated. Pregnancy (Cat.B). Labor & delivery, nursing mothers: not recommended. |
| Interactions |
|
Potentiation with alcohol, other CNS depressants, anticholinergics, MAOIs, tricyclic antidepressants, phenothiazines, general anesthetics, skeletal muscle relaxants. |
| Adverse Reactions |
|
Somnolence, constipation, GI upset, dizziness, pruritus, headache, dry mouth, sweating, asthenia, respiratory depression, hypotension. |
| How Supplied |
Caps—100
Conc soln—30mL (w. dropper) |
|
|
|
|
